Literature DB >> 3691614

Threshold hypnotic concentration of methohexitone.

P M Lauven1, H Schwilden, H Stoeckel.   

Abstract

Methohexitone was administered to 8 healthy adult volunteers as a microprocessor controlled infusion that generated 3 cycles of linearly increasing plasma levels with an anticipated slope of 0.2 microgram.ml-1.min-1. When a deep unconscious state was obtained, as indicated by burst suppression in the EEG, the infusion was stopped and then restarted when the volunteer was fully orientated. Frequent venous blood samples were obtained during and after the infusions to evaluate the threshold concentration at induced sleep and the return of orientation, at the loss and return of the eye lid reflex and corneal reflex, and the appearance and disappearance of EEG burst suppression patterns. From the first to the third infusion cycle only a slight and insignificant increase in the mean threshold concentrations was observed so the plasma levels were averaged over all three infusion cycles. The concentrations (microgram/ml) found were: asleep 3.39 and orientated 3.35, loss 4.42 and recurrence 4.32 of eye lid reflex, loss 6.51 and recurrence 5.18 of corneal reflex, and appearance 10.7 and disappearance 9.3 of burst suppression. Acute tolerance that would have led to a significant increase in threshold concentration from the first to the last infusion cycle was not demonstrated. If induced sleep and the appearance of EEG burst suppression are considered as clinical endpoints of anaesthesia, the therapeutic window of methohexitone covers a mean venous serum concentration range of 3.4 to 10.7 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691614     DOI: 10.1007/bf00637559

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Clinical comparison of thiopentone and methohexitone.

Authors:  J G WHITWAM; J M MANNERS
Journal:  Br Med J       Date:  1962-06-16

2.  Recovery time from methoexital anaesthesia.

Authors:  C JOLLY
Journal:  Br J Anaesth       Date:  1960-12       Impact factor: 9.166

3.  Acute tolerance to thiopentone in man.

Authors:  R D DRIPPS; J W DUNDEE; H L PRICE
Journal:  Br J Anaesth       Date:  1956-08       Impact factor: 9.166

4.  Recovery after methohexitone and thiopentone.

Authors:  C T Barry; R Lawson; D G Davidson
Journal:  Anaesthesia       Date:  1967-04       Impact factor: 6.955

5.  Clinical studies of induction agents. XV. A comparison of the cumulative effects of thiopentone, methohexitone and propidid.

Authors:  R S Clarke; J W Dundee
Journal:  Br J Anaesth       Date:  1966-05       Impact factor: 9.166

6.  Pharmacokinetics of methohexitone following intravenous infusion in humans.

Authors:  D D Breimer
Journal:  Br J Anaesth       Date:  1976-07       Impact factor: 9.166

7.  Barbiturate coma in focal cerebral ischemia. Relationship of protection to timing of therapy.

Authors:  W R Selman; R F Spetzler; R A Roski; U Roessmann; R Crumrine; R Macko
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

8.  [Pharmacokinetic studies following intravenous, intramuscular and rectal administration of methohexital in children].

Authors:  G Kraus; S Frank; R Knoll; H Prestele
Journal:  Anaesthesist       Date:  1984-06       Impact factor: 1.041

9.  [Dose-response relationship and serum concentrations of methohexital and hydroxymethohexital following rectal anesthesia induction with 1% and 5% methohexital solutions in children].

Authors:  W Engelhardt; W Ebert; I Rietbrock; E Richter
Journal:  Anaesthesist       Date:  1986-08       Impact factor: 1.041

Review 10.  Barbiturates in brain ischaemia.

Authors:  H M Shapiro
Journal:  Br J Anaesth       Date:  1985-01       Impact factor: 9.166

View more
  4 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

Review 2.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

3.  Alpha subunit isoform influences GABA(A) receptor modulation by propofol.

Authors:  M D Krasowski; S M O'Shea; C E Rick; P J Whiting; K L Hadingham; C Czajkowski; N L Harrison
Journal:  Neuropharmacology       Date:  1997-07       Impact factor: 5.250

4.  Methohexital in total intravenous anesthesia during intraoperative neurophysiological monitoring.

Authors:  Tod B Sloan; Jacqueline Vasquez; Evalina Burger
Journal:  J Clin Monit Comput       Date:  2013-06-29       Impact factor: 2.502

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.